At Axis-Shield, innovation is fundamental to our business. There is an increasing need for new diagnostic tests in many disease areas.
We are continually striving to develop improved methods to diagnose disease, employing both in-house expertise and our links with external centres of excellence.
Identifying these diseases quickly and efficiently can be vital in maintaining a patient's quality of life.
New drug treatments are evolving alongside innovative diagnostics, which is leading to improved patient management and monitoring of treatment efficacy.
At Axis-Shield, innovation is fundamental to our business. There is an increasing need for new diagnostic tests in many disease areas.
We are continually striving to develop improved methods to diagnose disease, employing both in-house expertise and our links with external centres of excellence.
Identifying these diseases quickly and efficiently can be vital in maintaining a patient's quality of life.
New drug treatments are evolving alongside innovative diagnostics, which is leading to improved patient management and monitoring of treatment efficacy.

Transparency in Supply Chains Statement

Transparency in Supply Chains Statement

Please follow this link to view the Abbott group’s Modern Slavery Act 2015 – Transparency in Supply Chains Statement for the year ended 31 December 2018 Signed and dated 11 July 2019

Axis Shield